Events

  1. Events
  2. Cell Therapy

Events Search and Views Navigation

Event Views Navigation

Today

Cell & Gene Therapy World Asia

Suntec Singapore Convention & Exhibition Centre 1 Raffles Boulevard Singapore, Singapore, Singapore

Gene and Cell Therapy Over 300 industry pioneers come together at World Asia, a premier event that has been held annually since 2017, to develop regenerative medicine and cell and gene therapy in Asia. The focus of this year's conference will be on innovations, manufacturing best practices, methods for scaling up, cost optimization, next-generation CAR-T medicines, and getting ready for commercialization. Prominent businesses including Tessa Therapeutics, Fosun Kite Biotechnology, BeiGene, and Gracell Biotechnologies will share their knowledge with attendees. The program provides a thorough examination of the most recent advancements in R&D, manufacturing, and commercialization. Come network with leading industry figures, discover state-of-the-art developments, and interact with unique case studies—all under one roof.

SDG $2295

Cell & Gene Therapy World Asia: (Solution Provider & Big Pharma)

Suntec Singapore Convention & Exhibition Centre 1 Raffles Boulevard Singapore, Singapore

Gathering more than 300 industry pioneers, Cell & Gene Therapy World Asia has been a premier event since 2017. The goal of the conference is to promote research, development, and production of high-quality regenerative medicines and cell and gene treatments across Asia. This year's event will address the following topics: next-generation CAR-T medicines, advancements in CAR-T manufacturing, best practices in the region, scale-out strategies, cost optimization, commercialization readiness, and regulatory case studies.

Come network with influential people and up-and-coming businesses including Fosun Kite Biotechnology, Gracell Biotechnologies, BeiGene, and more. All under one roof, learn about the most recent advancements in R&D and commercialization, as well as industry demands and special case studies.

SGD $4095

University of Melbourne Centre for Cancer Research Seminar

Lecture Theatre B, Lvl 7, VCCC 305 Grattan Street Lecture Theatre B, Level 7 , VIC 3052, Melbourne, Victoria

An overview of the Ontario Institute for Cancer Research's (OICR) principal programs, technological resources, research strategy, and international relationships will be provided by Dr. Laszlo Radvanyi, OICR President and Scientific Director. More than 325 researchers working in the fields of cancer genetics, molecular biology, biomarker development, and population health studies are housed at OICR, a leading Canadian cancer research funding organization, in Toronto. The goal of the institute is to improve cancer management and prevent relapse by translating state-of-the-art findings into practical applications, with a focus on liquid biopsies, precision oncology, and medicines. In addition, Dr. Radvanyi will discuss findings from his investigation into the function of retrotransposable elements in cancer, emphasizing new pathways and potential treatment targets.